- Home
- TALO vs RXRX Comparison
TALO vs RXRX Comparison
Compare TALO & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TALO | RXRX |
|---|---|---|
| Founded | 2011 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.2B |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TALO | RXRX |
|---|---|---|
| Price | $14.88 | $3.53 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 7 |
| Target Price | ★ $21.56 | $7.32 |
| AVG Volume (30 Days) | 3.9M | ★ 21.4M |
| Earning Date | 11-03-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.79 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,780,070,000.00 | $74,681,000.00 |
| Revenue This Year | $31.27 | N/A |
| Revenue Next Year | $2.19 | $49.16 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 26.92 |
| 52 Week Low | $10.15 | $2.77 |
| 52 Week High | $18.76 | $5.24 |
Technical Indicators
Market Signals| Indicator | TALO | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 34.28 | 45.03 |
| Support Level | $14.30 | $2.90 |
| Resistance Level | $15.96 | $3.66 |
| Average True Range (ATR) | 0.83 | 0.33 |
| MACD | -0.39 | -0.04 |
| Stochastic Oscillator | 17.98 | 10.05 |
Price Performance
Historical ComparisonAbout TALO Talos Energy Inc.
Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production. The company has operations in the United States, the Gulf of Mexico, and offshore Mexico. The company's operating segments are; exploration and production of oil, natural gas and NGLs, and the CCS segment. Its revenue is generated from the sale of oil, natural gas, and NGL quantities sold to purchasers.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.